Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This protocol is primarily looking to see if the IL-4Ra R576 polymorphism is associated with increased clinical, immunological and microbial markers of disease activity in patients with Atopic dermatitis.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 65
View:
• Male or female participants ≥6 to 65 yrs of age
• Meet AD Standard Diagnostic Criteria
Locations
United States
Massachusetts
Boston Children's Hospital
RECRUITING
Boston
Contact Information
Primary
Rachel Dabek, MD. MPH.
asthma@childrens.harvad.edu
857-218-5336
Backup
Hannah Foster
asthma@childrens.harvard.edu
857-218-3819
Time Frame
Start Date: 2020-11-30
Estimated Completion Date: 2027-09-15
Participants
Target number of participants: 111
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Leads: Boston Children's Hospital